Late Course Accelerated Hyperfractionation Radiotherapy for Esophageal Carcinoma

GAO Zong-yi,CHEN Jun,ZHAO Hong
2009-01-01
Abstract:Objective To study the long-term efficacy and toxicities of late course accelerated fractionation(LCAF) and conventional fractionation(CF) radiotherapy in the treatment of patients with esophageal carcinoma.Methods 64 patients with esophageal carcinoma were randomly divided into LCAF and CF radiotherapy groups.The 32 patients in the LCAF group were given 28 Gy in 1.4Gy/fraction,2 times a day,separated 4-6hours after 40 Gy of conventionally fractionated irradiation.Thirty-two patients in CF group received 70Gy of conventional irradiation.Results The complete response rate in the LCAF and CF group was 63% and 53%.The 1,3,5-year local control rate was 72%,55% and 17% in the LCAF group,and 52%,18%,8% in the CF group.The local control rate between the two groups was significantly different(P<0.05).The 1,3 and 5-yaer survival rate was 68%,50%,18% in the LCAF group,and 50%,30%,10% in the CF group.The difference between the two groups was significant(P<0.05).There was significant difference in the acute esophageal raditation reaction(P<0.05),but there was no significant difference in the acute trachea reaction(P>0.05)between the two group.There was no significant difference in late complications between the two group(P>0.05).Conclusion The local control rate and survival rate in LCAF group is higher than that in the CF group.LCAF radiotherapy is well tolerated with no increased toxicities.
What problem does this paper attempt to address?